small molecule

VIZZ

ACECLIDINE HYDROCHLORIDE

Loss of exclusivityMarch 2044latest FDA-listed patent expiry

CompanyLenz Therapeutics →See this company's full patent-cliff portfolio

Drug detail

Brand name	VIZZ
Active ingredient	ACECLIDINE HYDROCHLORIDE
Strength	EQ 1.44% BASE
Dosage form	SOLUTION/DROPS
Route	OPHTHALMIC
Modality	Small molecule
FDA approval	July 2025
Marketing status	RX

Listed patents

Patent	Expires	Type
12414942	March 2044	use U-3741
12128036	October 2039	use U-3741
12533347	October 2039	use U-3741
12653779	June 2035	use U-3741
11179328	March 2034	use U-3741
10052313	March 2034	product
9844537	March 2034	product

Regulatory exclusivity

Code	Expires
NCE	July 2030

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.